Navigation Links
Seahorse Bioscience Enters into Agreement with Primetech Corporation to Bring XF Technology to Japanese Market
Date:5/22/2008

Japanese Distributor to Expand Global Reach of Novel Technology

N. BILLERICA, Mass., May 22 /PRNewswire/ -- Seahorse Bioscience, leaders in real-time measurement of cellular bioenergetics, announced today that Primetech Corporation will become the exclusive supplier of Seahorse XF instruments and consumables in Japan.

"Japan's contribution to research and drug discovery is continuing to grow, as we have seen with the recent acquisition of Millennium by Takeda Pharmaceutical Company and with its increasing pipeline of new drugs in development," Mr. Ryosuke Ogihara, CEO of Primetech Corporation said. "Our customers are interested in studying mitochondrial dysfunction, and in particular its role in cancer, obesity and age-related diseases. Seahorse XF instruments offer the only practical way to study mitochondria in whole cells."

Introduced in June of 2006, Seahorse extracellular flux (XF) analyzers provide the first and only method to non-invasively measure the two major energy producing pathways -- mitochondrial respiration and glycolysis -- in living cells. The microplate-based technology allows scientists to assess the impact of drugs, genetic modifications and environment by monitoring the rate that cells consume oxygen and produce metabolic byproducts including acid and carbon dioxide.

"With a now well-established base of users in North America, we are expanding our reach to academic, biotech and pharma customers throughout the world" said Steve Chomicz, Vice President of Sales and Marketing at Seahorse. "We have chosen to work with Primetech after seeing their commitment to supporting their customers- an important factor in the introduction of innovative research instrumentation."

About Seahorse Bioscience, Inc.

Seahorse Bioscience is changing cancer, obesity, diabetes and age-related drug discovery programs the world over. Seahorse headquarters are located in North Billerica, Massachusetts. For more information, please visit http://www.seahorsebio.com.

About Primetech Corporation

For more than 15 years, Primetech Corporation has been a manufacturer and distributor of high technology medical and analytical science products throughout Japan. Primetech's focus on medical and analytical science products, a technically advanced staff, and an intimate knowledge of the Japanese marketplace allow it to assist companies in penetrating the Japanese market.

If you would like more information about Seahorse Bioscience, Inc., or would like to schedule a meeting with Steve Chomicz, please contact Kristine Hunt at 978-671-1610.


'/>"/>
SOURCE Seahorse Bioscience
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ardea Biosciences Announces Upcoming Corporate Meetings
2. Ardea Biosciences Reports Progress of Clinical Development Programs; Provides 2008 Outlook; Announces 2007 Financial Results and Provides 2008 Financial Guidance
3. Pressure BioSciences, Inc. Reports 2007 Financial Results and Provides Business Update
4. Pressure BioSciences, Inc. Announces Move to New Corporate Offices
5. Numira Biosciences Names New Board Member
6. DARA BioSciences, Inc. Announces Appointment of Dr. David J. Drutz to Board
7. DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of Merger
8. Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation
9. Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory
10. Ardea Biosciences Lead NNRTI for HIV, RDEA806, to Enter Phase 2a Proof-of- Concept Clinical Trial
11. Sangamo BioSciences Provides Update on Companys Accomplishments in 2007 and 2008 Objectives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 27, 2016 , ... Quality metrics are proliferating in cancer care, and are ... the eye of the beholder, according to experts who offered insights and commentary in ... Managed Care. For the full issue, click here . , For the American ...
(Date:6/26/2016)... ... ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a weight ... app plans to fix the two major problems leading the fitness industry today:, ... program , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
Breaking Medicine Technology: